Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02552953
Title A Pharmacologic Study of CYC065, a Cyclin Dependent Kinase Inhibitor, in Patients With Advanced Cancers
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cyclacel Pharmaceuticals, Inc.
Indications

Advanced Solid Tumor

lymphoma

Therapies

CYC065

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.